ASTA Follows Up with FDA on Saffron Holds and Rejections
ASTA Executive Director Laura Shumow met with U.S. Food and Drug Administration (FDA) officials regarding the increased inspection and detention of saffron shipments for economically motivated adulteration.
Membership Required
A valid ASTA membership is required to access this page. Please use the form below to log in with your ASTA member account.
Log in
Not a member yet? Click here to learn about joining ASTA today.
Related Resources
Cosmed Group Secures Six-Month Financing Amid Bankruptcy Proceedings
News & Updates
Industry News
12/10/2024
This is an article from the December 10, 2024, FYI ASTA newsletter.
ASTA-Supported Lead Limits Bill Passes New York Senate
News & Updates
Industry News
3/19/2025
Read this article about legislation supported by ASTA passing the New York State Senate.
